Similar presentations:
Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
1.
Worldwide burden of cancer attributable to diabetes and high body-mass index: acomparative risk assessment
Jonathan Pearson-Stuttard, BMBCh, Bin Zhou, MSc, Vasilis Kontis, PhD, James Bentham, PhD, Marc J Gunter, PhD, Prof Majid Ezzati,
FMed Sci
The Lancet Diabetes & Endocrinology
DOI: 10.1016/S2213-8587(17)30366-2
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC
BY 4.0 license Terms and Conditions
2.
Figure 1The Lancet Diabetes & Endocrinology DOI: (10.1016/S2213-8587(17)30366-2)
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC
BY 4.0 license Terms and Conditions
3.
Figure 2The Lancet Diabetes & Endocrinology DOI: (10.1016/S2213-8587(17)30366-2)
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC
BY 4.0 license Terms and Conditions
4.
Figure 3The Lancet Diabetes & Endocrinology DOI: (10.1016/S2213-8587(17)30366-2)
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC
BY 4.0 license Terms and Conditions